Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Higher interleukin-15 levels are linked to more severe alopecia areata, but not to age or gender.

Optimizing the structure of a specific compound greatly improved its effectiveness and precision for treating diabetic complications.

New genes linked to ichthyosis were found, but there's still no cure; treatment options are improving.

Over 150 new molecules with biological activities were found in traditional herbal medicines, some with potential for new drug development.

Eclipta prostrata is used for health benefits and hair care, showing various protective and healing effects.

People with Alopecia Areata often have lower vitamin D levels, and vitamin D supplements might help treat it.

A brain-produced steroid causes increased scratching in mice with a skin condition similar to eczema.

Men, particularly those with hair loss, are more likely to get the virus, and those with prostate cancer may have milder symptoms. Testosterone's role in the disease is unclear, and the virus doesn't seem to harm male fertility. Women with PCOS might be at higher risk. More research is needed.

CD2 might be a new treatment target for patchy alopecia areata.

New treatments for severe alopecia areata show promise but lack standard approval.

The document concludes that various dermatological treatments and drugs can cause skin reactions and side effects.

Oxidized LDL reduces cell growth but affects stem cell differentiation less negatively than cytokine-induced inflammation.

Alopecia areata treatment should be personalized, using topical or systemic therapies based on severity, with promising options like JAK inhibitors needing more research.

Higher IL-31 levels are linked to worse itching in chronic kidney disease patients.

Alopecia Areata has no cure, treatments are limited, and the condition often recurs, but new therapies like JAK inhibitors show promise.

Antiandrogens and androgen inhibitors like spironolactone, finasteride, and dutasteride can treat hair loss and skin conditions, but they have risks and side effects, including potential harm to pregnant women and risks of cancer and heart issues. Herbal remedies also have antiandrogenic effects but lack safety validation.

Botulinum toxin type A significantly reduces scalp psoriasis severity compared to placebo.

Obesity negatively affects the endometrium, leading to higher miscarriage risk and impaired cell function.

Hair loss in Lichen Planopilaris is caused by immune system issues damaging hair follicles and stem cells.

Higher prolactin levels are linked to psoriasis, alopecia areata, and vitiligo severity.

Alopecia areata and atopic dermatitis share immune system issues, and treatments like JAK inhibitors can help both.

T-regulatory cells are important for skin health and can affect hair growth and reduce skin inflammation.

Blocking certain proteins can significantly regrow hair in severe alopecia areata.

Certain gene changes in osteopontin are linked to higher risk of atopic dermatitis and asthma.

A JAK inhibitor improved both severe hair loss and chronic skin disease in one patient.

Engineering strategies improve stem cells' ability to heal wounds effectively.

Adenosine receptors could be promising targets for treating inflammatory skin diseases like psoriasis.

Iron deficiency worsens inflammatory skin diseases by disrupting iron balance and increasing inflammation.

Low vitamin D may increase autoimmune thyroid disease risk, but its treatment effects are unclear.

Exosome-based therapies show promise for treating alopecia areata but need more research.